Author: OurCrowd

[Biolojic in Business Wire] Aulos Bioscience receives HREC approval to initiate first-in-human clinical trial evaluating anti-tumor activity of novel IL-2 therapeutic AU-007

LARKSPUR, Calif.–(BUSINESS WIRE)–Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, today announced that it has obtained approval from the Monash Health Human Research Ethics Committee (HREC) to initiate a Phase 1/2, first-in-human trial of AU-007, a monoclonal antibody computationally designed by Biolojic Design. AU-007 leverages a highly differentiated approach to harnessing the power of interleukin-2 (IL-2) to eradicate solid tumors. Read...

Read More

[DailyPay in Payments Journal] PNC Treasury Management Launches Innovative On-Demand Pay Solution Powered by DailyPay

PITTSBURGH, Feb. 23, 2022 – PNC Treasury Management today announced a groundbreaking new on-demand pay solution, PNC EarnedIt. Powered by DailyPay Marketplace, PNC EarnedIt offers pay on-demand – a highly sought-after employee-benefit – to its clients allowing them to provide their employees access to earned pay – throughout any point in the pay cycle – prior to payday. Read...

Read More